Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
About a quarter of people taking a higher dose of Ocaliva saw an improvement in liver fibrosis.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
This finding may help explain why people with the disease struggle to lose weight.
Fatty, sugary food can be especially tempting during the holidays. Ask Hep makes some suggestions for those with fatty liver disease.
Experimental therapy led to weight loss and improved biomarkers of liver health.
Nonetheless, half of people with NAFLD were able to reach a 5% weight loss goal using a very low energy diet.
Well-tolerated insulin sensitizer may play a role in the treatment of fatty liver disease.
Drugs that have a favorable effect on biomarkers may still play a role in combination therapy, however.
The application is based on study results showing that up to 23% of treated patients saw an improvement in liver fibrosis.
Researchers call for greater use of noninvasive measures of fatty liver disease in this population to identify those at risk.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
Rising rates of obesity are fueling the epidemic.
Liver damage can be caused by many factors such as hepatitis, cirrhosis, fatty liver, and other liver disease conditions.
Study finds people who took daily aspirin had a lower risk of NASH and advanced liver scarring.
A look at 3 forms of fatty liver disease: Non-Alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis
Good nutrition is essential for a healthy liver. However, with all the hype about food, how do you know what the healthiest diet is?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.